True North Therapeutics
A pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need.
Launch date
Employees
Market cap
-
Enterprise valuation
€364m (Public information from May 2017)
San Francisco California (HQ)
Authorizing premium user...